CN116637062A - Method for preparing rejuvenation liquid - Google Patents
Method for preparing rejuvenation liquid Download PDFInfo
- Publication number
- CN116637062A CN116637062A CN202310737092.0A CN202310737092A CN116637062A CN 116637062 A CN116637062 A CN 116637062A CN 202310737092 A CN202310737092 A CN 202310737092A CN 116637062 A CN116637062 A CN 116637062A
- Authority
- CN
- China
- Prior art keywords
- preparing
- garlicin
- sterilizing
- extract
- allicin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 18
- 230000003716 rejuvenation Effects 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000001954 sterilising effect Effects 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 19
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 18
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims abstract description 13
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000010081 allicin Nutrition 0.000 claims abstract description 13
- 241001474374 Blennius Species 0.000 claims abstract description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 11
- 102000008186 Collagen Human genes 0.000 claims abstract description 10
- 108010035532 Collagen Proteins 0.000 claims abstract description 10
- 229920001436 collagen Polymers 0.000 claims abstract description 10
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 239000012043 crude product Substances 0.000 claims abstract description 10
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 10
- 238000004806 packaging method and process Methods 0.000 claims abstract description 10
- 229960000271 arbutin Drugs 0.000 claims abstract description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000047 product Substances 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims abstract description 6
- 108090000790 Enzymes Proteins 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 5
- 229940044176 ceramide 3 Drugs 0.000 claims abstract description 5
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 239000008236 heating water Substances 0.000 claims abstract description 5
- 239000011265 semifinished product Substances 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 240000002234 Allium sativum Species 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 235000004611 garlic Nutrition 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 229940118127 fucus vesiculosus extract Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 229940106189 ceramide Drugs 0.000 claims description 4
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000005360 mashing Methods 0.000 claims description 4
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000005988 Sea-algae extract (formerly sea-algae extract and seaweeds) Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 230000001914 calming effect Effects 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 241000195474 Sargassum Species 0.000 abstract 1
- 239000003344 environmental pollutant Substances 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a preparation method of a rejuvenation liquid, which specifically comprises the following steps: firstly, mixing glycerol and collagen for standby, then heating water to 100 ℃, and cooling to 85 ℃; cleaning and sterilizing the emulsifying cylinder, sequentially adding arbutin, sodium hyaluronate and ceramide 3 into the emulsifying cylinder, heating and stirring to dissolve uniformly, and cooling to normal temperature; placing allicin, seaweed extract and hydrolyzed silk in a high-speed mixing container for continuous rotary mixing, and standing to obtain a semi-finished product of the skin-refreshing liquid; and (3) sterilizing the crude product of the new myowater, and then injecting the sterilized crude product into a packaging bottle for packaging to obtain a finished product. The garlicin is adopted to match with other components, so that the garlicin has the functions of powerful antioxidation and aging resistance, whitening and moisturizing, sterilizing and calming skin, and meanwhile, the garlicin is subjected to enzyme catalysis extraction, so that the components of the new myowater are more stable; the Sargassum extract and sodium hyaluronate act together to provide excellent moisture keeping effect.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to a preparation method of a rejuvenation liquid.
Background
In recent years, with the progress of industrialization and urbanization, environmental pollution problems have caused great trouble to the nations. In polluted air, the largest organ of the human body, namely skin, is inevitably a first defense line for blocking pollutants, and is one of the ways for the pollutants to enter the body.
Research shows that in the environment polluted by air, the incidence rate of various inflammatory skin diseases is obviously increased, and more feared, particles and volatile organic compounds can form a synergistic effect with ultraviolet rays, so that the sensitivity of the skin to pollution is increased, and meanwhile, the moisture content of the skin is reduced, the barrier function is damaged, and the skin is damaged, such as dryness, looseness and the like. The existing skin care products can enable skin to be rapidly supplemented with water, lack of moisturizing factors, easily cause tragic white and matt faces, cannot nourish the skin fundamentally, and have poor repairing effect on the skin.
Disclosure of Invention
The invention aims to provide a manufacturing method of a rejuvenation liquid to solve the problems in the background technology. In order to achieve the above purpose, the present invention provides the following technical solutions: the preparation method of the rejuvenation liquid specifically comprises the following steps:
step one, preparing the following raw materials in percentage by weight: 10-15% of allicin, 5-6% of arbutin, 312-15% of ceramide, 3-6% of seaweed extract, 7-10% of hydrolyzed silk, 1-2% of sodium hyaluronate, 1-2% of collagen, 2-3% of glycerol and the balance of water;
step two, firstly mixing glycerol and collagen for standby, then heating water to 100 ℃, and cooling to 85 ℃;
step three, cleaning and sterilizing an emulsifying cylinder, sequentially adding arbutin, sodium hyaluronate and ceramide 3 into the emulsifying cylinder, heating and stirring to dissolve uniformly, and cooling to normal temperature;
placing allicin, seaweed extract and hydrolyzed silk in a high-speed mixing container for continuous rotary mixing, and then standing to obtain a semi-finished product of the rejuvenating liquid;
and fifthly, sterilizing the crude product of the new myowater, and filling the sterilized crude product into a packaging bottle for packaging to obtain a finished product.
Preferably, the method for manufacturing the allicin in the first step comprises the following steps: mashing fresh garlic into mashed garlic, adding catalytic enzyme, performing constant temperature enzymolysis at 40-50deg.C for 100-120min to obtain enzymolysis solution, filtering the enzymolysis solution to obtain filtrate, centrifuging the filtrate in a centrifuge to obtain garlicin solution, and concentrating under reduced pressure to obtain garlicin for use.
Preferably, the seaweed extract in the step one is gulfweed extract and Fucus vesiculosus extract.
Preferably, the rotation mixing parameter in the fourth step is the rotation speed of 7500-8500r/min, the time of 60-70min and the standing time of 80-100min.
Preferably, in the fifth step, sterilization is performed by ultraviolet sterilization.
Compared with the prior art, the invention has the following beneficial effects:
the garlicin is adopted to match with other components, so that the garlicin has the functions of powerful antioxidation and aging resistance, whitening and moisturizing, sterilizing and calming skin, and meanwhile, the garlicin is subjected to enzyme catalysis extraction, so that the components of the new myowater are more stable; the gulfweed extract and sodium hyaluronate act together to have excellent moisturizing effect; the Fucus vesiculosus extract has contraction effect on collagen gel, and can prevent vasodilation; promoting pigment decomposition and homogenizing skin color; the hydrolyzed silk can promote secretion of collagen, and restore and enhance skin tension and elasticity.
Detailed Description
In order to make the technical means, creation features, workflow, and usage method of the present invention achieve the objects and effects of the present invention easy to understand, the technical solutions of the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
The preparation method of the rejuvenation liquid specifically comprises the following steps:
step one, preparing the following raw materials in percentage by weight: 10% of allicin, 5% of arbutin, 312% of ceramide, 3% of seaweed extract, 7% of hydrolyzed silk, 1% of sodium hyaluronate, 1% of collagen, 2% of glycerol and the balance of water;
step two, firstly mixing glycerol and collagen for standby, then heating water to 100 ℃, and cooling to 85 ℃;
step three, cleaning and sterilizing an emulsifying cylinder, sequentially adding arbutin, sodium hyaluronate and ceramide 3 into the emulsifying cylinder, heating and stirring to dissolve uniformly, and cooling to normal temperature;
placing allicin, seaweed extract and hydrolyzed silk in a high-speed mixing container for continuous rotary mixing, and then standing to obtain a semi-finished product of the rejuvenating liquid;
and fifthly, sterilizing the crude product of the new myowater, and filling the sterilized crude product into a packaging bottle for packaging to obtain a finished product.
The manufacturing method of the allicin in the first step comprises the following steps: mashing fresh garlic into mashed garlic, adding catalytic enzyme, performing constant temperature enzymolysis at 50deg.C for 100min to obtain enzymolysis solution, filtering the enzymolysis solution to obtain filtrate, centrifuging the filtrate in a centrifuge to obtain garlicin solution, and concentrating under reduced pressure to obtain garlicin for use.
Wherein the seaweed extract in the step one is gulfweed extract and Fucus vesiculosus extract.
The rotating mixing parameter in the fourth step is the rotating speed of 7500r/min, the time of 60min and the standing time of 80min.
And in the fifth step, sterilization is performed by adopting an ultraviolet sterilization mode.
Example 2
The preparation method of the rejuvenation liquid specifically comprises the following steps:
step one, preparing the following raw materials in percentage by weight: 15% of allicin, 6% of arbutin, 315% of ceramide, 6% of seaweed extract, 10% of hydrolyzed silk, 2% of sodium hyaluronate, 2% of collagen, 3% of glycerol and the balance of water;
step two, firstly mixing glycerol and collagen for standby, then heating water to 100 ℃, and cooling to 85 ℃;
step three, cleaning and sterilizing an emulsifying cylinder, sequentially adding arbutin, sodium hyaluronate and ceramide 3 into the emulsifying cylinder, heating and stirring to dissolve uniformly, and cooling to normal temperature;
placing allicin, seaweed extract and hydrolyzed silk in a high-speed mixing container for continuous rotary mixing, and then standing to obtain a semi-finished product of the rejuvenating liquid;
and fifthly, sterilizing the crude product of the new myowater, and filling the sterilized crude product into a packaging bottle for packaging to obtain a finished product.
The manufacturing method of the allicin in the first step comprises the following steps: mashing fresh garlic into mashed garlic, adding catalytic enzyme, performing constant temperature enzymolysis at 40deg.C for 120min to obtain enzymolysis solution, filtering the enzymolysis solution to obtain filtrate, centrifuging the filtrate in a centrifuge to obtain garlicin solution, and concentrating under reduced pressure to obtain garlicin for use.
Wherein the seaweed extract in the step one is gulfweed extract and Fucus vesiculosus extract.
Wherein the rotation mixing parameter in the fourth step is the rotation speed of-8500 r/min, the time is 70min, and the standing time is 100min.
And in the fifth step, sterilization is performed by adopting an ultraviolet sterilization mode.
The foregoing has shown and described the basic principles, main features and advantages of the present invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, and that the above embodiments and descriptions are merely illustrative of the principles of the present invention, and various changes and modifications may be made without departing from the spirit and scope of the invention, which is defined in the appended claims. The scope of the invention is defined by the appended claims and equivalents thereof.
Claims (5)
1. The preparation method of the rejuvenation liquid is characterized by comprising the following steps of:
step one, preparing the following raw materials in percentage by weight: 10-15% of allicin, 5-6% of arbutin, 312-15% of ceramide, 3-6% of seaweed extract, 7-10% of hydrolyzed silk, 1-2% of sodium hyaluronate, 1-2% of collagen, 2-3% of glycerol and the balance of water;
step two, firstly mixing glycerol and collagen for standby, then heating water to 100 ℃, and cooling to 85 ℃;
step three, cleaning and sterilizing an emulsifying cylinder, sequentially adding arbutin, sodium hyaluronate and ceramide 3 into the emulsifying cylinder, heating and stirring to dissolve uniformly, and cooling to normal temperature;
placing allicin, seaweed extract and hydrolyzed silk in a high-speed mixing container for continuous rotary mixing, and then standing to obtain a semi-finished product of the rejuvenating liquid;
and fifthly, sterilizing the crude product of the new myowater, and filling the sterilized crude product into a packaging bottle for packaging to obtain a finished product.
2. The method for preparing the rejuvenating liquid according to claim 1, which is characterized in that: the manufacturing method of the allicin in the first step comprises the following steps: mashing fresh garlic into mashed garlic, adding catalytic enzyme, performing constant temperature enzymolysis at 40-50deg.C for 100-120min to obtain enzymolysis solution, filtering the enzymolysis solution to obtain filtrate, centrifuging the filtrate in a centrifuge to obtain garlicin solution, and concentrating under reduced pressure to obtain garlicin for use.
3. The method for preparing the rejuvenating liquid according to claim 1, which is characterized in that: the sea algae extract in the step one is gulfweed extract and Fucus vesiculosus extract.
4. The method for preparing the rejuvenating liquid according to claim 1, which is characterized in that: the rotation mixing parameter in the fourth step is that the rotation speed is 7500-8500r/min, the time is 60-70min, and the standing time is 80-100min.
5. The method for preparing the rejuvenating liquid according to claim 1, which is characterized in that: and in the fifth step, sterilization is performed by adopting an ultraviolet sterilization mode.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310737092.0A CN116637062A (en) | 2023-06-21 | 2023-06-21 | Method for preparing rejuvenation liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310737092.0A CN116637062A (en) | 2023-06-21 | 2023-06-21 | Method for preparing rejuvenation liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116637062A true CN116637062A (en) | 2023-08-25 |
Family
ID=87623056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310737092.0A Withdrawn CN116637062A (en) | 2023-06-21 | 2023-06-21 | Method for preparing rejuvenation liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116637062A (en) |
-
2023
- 2023-06-21 CN CN202310737092.0A patent/CN116637062A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104688615A (en) | Enzyme facial mask essence with moisturizing and whitening functions | |
| CN105012225A (en) | Beauty and skincare enzyme liquid and application thereof | |
| CN107095313B (en) | Collagen oral liquid | |
| CN103169953A (en) | Collagen peptide-colla corii asini oral solution and preparation method thereof | |
| CN103565729A (en) | Lycium ruthenicum mill moisturizing and repairing aqua gel and preparation method of aqua gel | |
| CN111700814A (en) | Soothing and repairing mask containing cannabis sativa leaf extract and preparation method of soothing and repairing mask | |
| CN110974773A (en) | Skin care product for anti-allergic repair and preparation method thereof | |
| CN116637062A (en) | Method for preparing rejuvenation liquid | |
| CN112715815A (en) | Cod micromolecular collagen peptide solid beverage | |
| CN108309851A (en) | A kind of face cream with anti-senescence function | |
| CN116617138A (en) | Anti-wrinkle whitening composition containing marine protein, and preparation method and application thereof | |
| CN111759762A (en) | Black eye removing composition, essence and preparation method thereof | |
| CN111544314A (en) | Lifting and tightening freeze-dried mask composition containing elm bark extract and preparation method thereof | |
| CN108888554B (en) | Stem cell beauty emulsion with skin tendering and spot lightening functions and preparation method thereof | |
| CN116531485A (en) | Preparation method of human anti-aging cell substance | |
| CN114191349A (en) | Anti-aging composition and preparation method and application thereof | |
| CN109528602A (en) | A kind of plant fermentation composition, preparation method and its application | |
| CN106606448A (en) | Antioxidant enzyme mask liquid | |
| CN108113916B (en) | Natural repair peptide mask liquid and preparation method thereof | |
| CN106755177B (en) | Preparation of rhamnooligosaccharide from green algae and application of rhamnooligosaccharide in cosmetics | |
| CN111053721A (en) | Silky glowing eye cream and preparation method thereof | |
| CN111481476A (en) | Potato facial mask with multiple skin care effects and preparation method thereof | |
| CN105211879A (en) | A kind of processing technology utilizing natural plants to prepare blueberry composite enzyme | |
| CN112370400A (en) | Metaplexis japonica transdermal fibronectin barrier recombination repair stock solution and preparation method thereof | |
| CN109662905A (en) | It is a kind of to promote cytothesis, cultivate, regenerate the stoste of maintenance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230825 |
|
| WW01 | Invention patent application withdrawn after publication |